IQVIA
IQV • NYSE
IQVIA is a medical - diagnostics & research company in the healthcare sector trading on NYSE, led by CEO Ari Bousbib, with a market cap of $30.0B.
CEOAri Bousbib
Market Cap$30.0B
Medical - Diagnostics & Research
Healthcare
Employees88.0K
Websiteiqvia.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for IQVIA
Date
Tuesday, May 5, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$2.71
Revenue Estimate
$4.1B
Earnings History
Past 12 earnings reports for IQVIA
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 5, 2026 | Q4 2025 | $3.42Est: $3.29 | +4.0% | $4.4BEst: $4.2B | +2.9% |  10-K |
| Oct 28, 2025 | Q3 2025 | $3.00Est: $2.86 | +4.9% | $4.1BEst: $4.1B | +0.6% | — |
| Jul 22, 2025 | Q2 2025 | $2.81Est: $2.66 | +5.6% | $4.0BEst: $4.0B | +1.4% | 10-Q |
| May 6, 2025 | Q1 2025 | $2.70Est: $2.63 | +2.7% | $3.8BEst: $3.8B | +1.6% | 10-Q |
| Feb 6, 2025 | Q4 2024 | $3.12Est: $3.11 | +0.3% | $4.0BEst: $3.9B | +0.7% | 10-K |
| Oct 31, 2024 | Q3 2024 | $2.84Est: $2.81 | +1.1% | $3.9BEst: $3.9B | +0.9% | 10-Q |
| Jul 22, 2024 | Q2 2024 | $2.64Est: $2.56 | +3.1% | $3.8BEst: $3.8B | +0.6% | 10-Q |
| May 2, 2024 | Q1 2024 | $2.54Est: $2.48 | +2.4% | $3.7BEst: $3.7B | +1.0% | 10-Q |
| Feb 14, 2024 | Q4 2023 | $2.84Est: $2.82 | +0.7% | $3.9BEst: $3.8B | +2.1% | 10-K |
| Nov 1, 2023 | Q3 2023 | $2.49Est: $2.44 | +2.0% | $3.7BEst: $3.8B | -1.2% | — |
| Aug 1, 2023 | Q2 2023 | $2.43Est: $2.37 | +2.5% | $3.7BEst: $3.7B | +0.6% | 10-Q |
| Apr 27, 2023 | Q1 2023 | $2.45Est: $2.41 | +1.7% | $3.7BEst: $3.6B | +1.2% | 10-Q |